Literature DB >> 14677079

Genetics of schizophrenia and affective disorders.

W Maier1, A Zobel, M Rietschel.   

Abstract

The molecular-genetic basis of non-mendelian, genetically influenced disorders (complex disorders) is beginning to be uncovered. Recently, major progress in localization and detection of disposition genes of schizophrenia and bipolar disorder was achieved. We provide a comprehensive overview of recent results of linkage and association studies in schizophrenia and bipolar disorder. Several disposition genes for schizophrenia (DTNBP1, NRG1, G72) were identified, whereas evidence for specific disposition genes in bipolar disorder is more limited. Multiple limitations of current research strategies in the search of disposition genes of complex disorders have to be considered; alternative phenotype definitions, genome-wide association studies and parallel investigation of epigenetic misregulations might overcome these limitations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14677079     DOI: 10.1055/s-2003-45130

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  9 in total

Review 1.  [Genetic and brain structure anomalies in autism spectrum disorders. Towards an understanding of the aetiopathogenesis?].

Authors:  T Nickl-Jockschat; T M Michel
Journal:  Nervenarzt       Date:  2011-05       Impact factor: 1.214

2.  Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios.

Authors:  M Daniele Fallin; Virginia K Lasseter; Dimitrios Avramopoulos; Kristin K Nicodemus; Paula S Wolyniec; John A McGrath; Gary Steel; Gerald Nestadt; Kung-Yee Liang; Richard L Huganir; David Valle; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2005-10-28       Impact factor: 11.025

Review 3.  The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

4.  Reduced Hippocampal Volume and Its Relationship With Verbal Memory and Negative Symptoms in Treatment-Naive First-Episode Adolescent-Onset Schizophrenia.

Authors:  Xujun Duan; Changchun He; Jianjun Ou; Runshi Wang; Jinming Xiao; Lei Li; Renrong Wu; Yan Zhang; Jingping Zhao; Huafu Chen
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

Review 5.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

6.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

Authors:  Konrad Talbot; Wess L Eidem; Caroline L Tinsley; Matthew A Benson; Edward W Thompson; Rachel J Smith; Chang-Gyu Hahn; Steven J Siegel; John Q Trojanowski; Raquel E Gur; Derek J Blake; Steven E Arnold
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

7.  Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression.

Authors:  M K Hahn; J U Blackford; K Haman; M Mazei-Robison; B A English; H C Prasad; A Steele; L Hazelwood; H M Fentress; R Myers; R D Blakely; E Sanders-Bush; R Shelton
Journal:  Genes Brain Behav       Date:  2007-12-06       Impact factor: 3.449

8.  Burden of relatives and predictors of burden. Baseline results from the Munich 5-year-follow-up study on relatives of first hospitalized patients with schizophrenia or depression.

Authors:  Anne Maria Möller-Leimkühler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-19       Impact factor: 5.270

Review 9.  Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.

Authors:  Yoshiki Takamatsu; Gilbert Ho; Masaaki Waragai; Ryoko Wada; Shuei Sugama; Takato Takenouchi; Eliezer Masliah; Makoto Hashimoto
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.